Hiroshi Masuda Selected Research

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

1/2022	Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease.
3/2019	Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
1/2018	Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.
1/2018	Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease.
1/2017	Effective therapy with infliximab for clinically mild encephalitis/encephalopathy with a reversible splenial lesion in an infant with Kawasaki disease.
1/2017	[Transient detection of lupus anticoagulant in acute phase of Kawasaki disease].
12/2014	Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Masuda Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 01/2002
13	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 03/2003
10	Hypothalamic hamartomas 01/2022 - 08/2007
7	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 12/2014
7	Neoplasm Metastasis (Metastasis) 07/2021 - 03/2003
4	Fever (Fevers) 10/2018 - 01/2017
4	Seizures (Absence Seizure) 01/2017 - 10/2006
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013 - 04/2012
4	Type 2 Diabetes Mellitus (MODY) 01/2009 - 03/2006
3	Pain (Aches) 01/2023 - 07/2017
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2022 - 12/2003
3	Hypertension (High Blood Pressure) 07/2021 - 04/2005
3	Hemorrhage 10/2018 - 01/2005
3	Iron Deficiencies 04/2018 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 03/2012
3	Hypoxia (Hypoxemia) 01/2016 - 01/2012
3	Gastritis 06/2009 - 01/2003
3	Atherosclerosis 01/2009 - 07/2002
2	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 07/2021
2	Inflammation (Inflammations) 01/2023 - 01/2017
2	Visceral Pain 01/2023 - 07/2019
2	Hyperalgesia 01/2023 - 07/2019
2	Heart Failure 07/2021 - 08/2017
2	Tuberous Sclerosis (Bourneville's Disease) 10/2015 - 05/2013
2	Epilepsy (Aura) 05/2013 - 11/2002
2	Hamartoma 05/2013 - 08/2007
2	Fibrosis (Cirrhosis) 01/2013 - 07/2012
2	Liver Neoplasms (Liver Cancer) 07/2012 - 03/2012
2	Partial Epilepsies (Epilepsy, Partial) 09/2011 - 08/2007
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2009 - 04/2002
2	Infections 02/2007 - 10/2003
2	Lymphatic Metastasis 12/2003 - 12/2002
1	Pneumoperitoneum 04/2024
1	COVID-19 03/2024
1	Back Pain (Backache) 03/2023
1	Pathologic Constriction (Stenosis) 03/2023
1	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2023
1	Cystitis 01/2023
1	Pancreatitis 01/2023
1	Disease Progression 12/2022
1	Overactive Urinary Bladder (Overactive Bladder) 12/2022
1	Dyskinesias (Dyskinesia) 01/2022
1	Hot Flashes 11/2021

Drug/Important Bio-Agent (IBA)

7	AndrogensIBA 01/2023 - 04/2004
5	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2007
4	IronIBA 04/2018 - 01/2012
4	erucylphosphocholineIBA 01/2016 - 03/2012
3	Infliximab (Remicade)FDA Link 01/2022 - 01/2017
3	Ferritins (Ferritin)IBA 01/2021 - 01/2012
3	Immunoglobulins (Immunoglobulin)IBA 03/2019 - 12/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 06/2012
3	Fibrinogen (Factor I)FDA Link 11/2006 - 07/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024 - 01/2017
2	sodium sulfideIBA 01/2023 - 07/2019
2	Dutasteride (Avodart)FDA Link 12/2022 - 10/2014
2	AlbuminsIBA 07/2021 - 01/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019 - 09/2003
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2018 - 07/2017
2	trans-sodium crocetinate (crocetin)IBA 10/2015 - 05/2013
2	Chelating AgentsIBA 01/2013 - 01/2012
2	Messenger RNA (mRNA)IBA 06/2012 - 04/2004
2	Hemoglobins (Hemoglobin)IBA 01/2007 - 11/2006
2	LipidsIBA 11/2006 - 07/2002
2	Bone Morphogenetic Protein 7IBA 04/2004 - 03/2003
1	Carbon DioxideIBA 04/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	Colchicine FDA LinkGeneric 03/2024
1	Tolvaptan FDA Link 03/2023
1	LyasesIBA 01/2023
1	CeruletideIBA 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	EnzymesIBA 01/2023
1	GermaniumIBA 01/2023
1	GasotransmittersIBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	CystathionineIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	SulfurIBA 01/2023
1	3-(trihydroxygermyl)propanoic acidIBA 01/2023
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 12/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	8-hydroxyguanineIBA 10/2021
1	CytosineIBA 10/2021

Therapy/Procedure

26	Therapeutics 03/2024 - 04/2002
9	Electrocoagulation (Electrocautery) 01/2022 - 08/2007
3	Transplantation 01/2013 - 04/2012
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2003 - 01/2002
2	Stents 03/2023 - 02/2002
2	Plasma Exchange 01/2022 - 12/2014
2	Renal Dialysis (Hemodialysis) 07/2021 - 07/2017
2	Castration 01/2021 - 10/2018
2	Extracorporeal Shockwave Therapy 12/2012 - 10/2011
2	Electrodes (Electrode) 10/2006 - 11/2002
2	Drug Therapy (Chemotherapy) 12/2002 - 02/2002
1	Prostatectomy (Retropubic Prostatectomy) 04/2024
1	Solid-State Lasers 03/2023
1	Deep Brain Stimulation 01/2022
1	Radiotherapy 11/2021